Cargando…
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 1: amitriptyline
OBJECTIVE: The aim of this paper is to critically re-appraise the published trials assessing amitriptyline for migraine prophylaxis. METHODS: We report our methods and results following the Preferred Reporting Items for Systematic Reviews (PRISMA), by searching MEDLINE, EMBASE, Cochrane CENTRAL, and...
Autores principales: | Lampl, Christian, Versijpt, Jan, Amin, Faisal Mohammad, Deligianni, Christina I., Gil-Gouveia, Raquel, Jassal, Tanvir, MaassenVanDenBrink, Antoinette, Ornello, Raffaele, Paungarttner, Jakob, Sanchez-del-Rio, Margarita, Reuter, Uwe, Uluduz, Derya, de Vries, Tessa, Zeraatkar, Dena, Sacco, Simona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088191/ https://www.ncbi.nlm.nih.gov/pubmed/37038134 http://dx.doi.org/10.1186/s10194-023-01573-6 |
Ejemplares similares
-
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 2: flunarizine
por: Deligianni, Christina I., et al.
Publicado: (2023) -
The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis
por: Lampl, Christian, et al.
Publicado: (2023) -
European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3: topiramate
por: Raffaelli, Bianca, et al.
Publicado: (2023) -
European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure
por: Sacco, Simona, et al.
Publicado: (2022) -
European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update
por: Sacco, Simona, et al.
Publicado: (2022)